Pfizer Inc. PFE

Ex div date

$PFE
Love the dividend. 2026 will be the year of dividend paying stocks.

PFE Market cap still at $400 M after 80% pop. This should trade above $2-5 billions range like other mineral stocks . Expect to run this stock throughput the week and make massive profits.
No pressure - just thought you might find the introduction useful

Text&Wassup+44/ 7/4/4/6/0/6/6/2/9/5
Telegram link trading view at ?
t.me/financeCryptoGlobalExchange

$PFE Market cap still at $400 M after 80% pop. This should trade above $2-5 billions range like other mineral stocks . Expect to run this stock throughput the week and make massive profits.
No pressure - just thought you might find the introduction useful

Text&Wassup+44/ 7/4/4/6/0/6/6/2/9/5

$NWBO. Real science ready to squeeze

Northwest Biotherapeutics Announces That Its Acquisition of Advent BioServices Ltd. Has Closed
Northwest Biotherapeutics, Inc.

News provided by

Oct 24, 2025, 12:03 ET

BETHESDA, Md., Oct. 24, 2025 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (OTCQB:NWBO) (the "Company" or "NWBio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced that its acquisition of Advent BioServices Ltd. ("Advent") has closed. As a result of this acquisition, Advent is now a wholly owned subsidiary of NWBio.

The Company anticipates that this acquisition will help enable efficiencies and scale-up of operations. The Company believes that integration of the companies can result in:

A fully integrated platform combining the technologies, expertise and intellectual property of NWBio, Advent and Flaskworks;
Streamlining and efficiencies in supply chain management and facilities management;
Closing of operations at the GMP facility in London and reallocation of resources to the Sawston, UK facility and to capacity development in the US;
Facilitating scale-up of manufacturing capacity;
Streamlining and efficiencies in interactions with clinical sites and distribution of DCVax products.
As previously announced, through the acquisition of Advent, NWBio is receiving all of Advent's fixed assets, including extensive cryostorage and other equipment purchased by Advent over the last several years. Intellectual property and other intangibles that Advent had acquired are also included.

The Company is not issuing any shares or other securities in connection with acquiring Advent. On the contrary, 19 million NWBio securities (13.5 million shares and 5.5 million options) that were previously issued to Advent as payment for contract services are reverting back to the Company along with the acquisition of the other Advent assets.

The consideration for the acquisition will be paid in installments over two years, with potential acceleration after regulatory approval of the Company's DCVax®-L product. The consideration consists of a payment of £1.4 million and payment of the net amount of accounts payable ("Net AP") already due from the Company to Advent for services under existing contracts. The acquisition agreement was updated to provide that the installment payments will not begin until 90 days after the October closing, rather than 90 days after the August agreement, and the Net AP is likewise being determined as of the closing date.

"We are excited to have completed the necessary conditions for closing the acquisition of Advent, and to be moving into position for potential significant scale-up," commented Linda Powers, the Company's CEO. "We believe this integration can also help accelerate development of additional applications and next-generation versions of our technologies, applying the combined expertise and the large portfolio of intellectual property that we have amassed. We believe this represents important progress in building a dominant franchise."

MRNA Moderna and PFE Pfizer should go broke for their mRNA poison jabs! Oh what about the false claims made 1 get the jab won't get sick 2 get the jab can't transmit the disease 3 they are safe and effective

Safe really OMG myocarditis, cardiomyopathy, blood clots, autoimmune issues plus maybe long covid cause maybe long term spike proteins in the body!

Criminals

Accumulate. 7% Dividend appears very safe. Enjoy that for life of ownership. Very low downside risk at this stage. This is buying time in my opinion.

7% dividend with very low downside = nice long term play.

$NWBO. $MERK. It looks like Merck is getting ready to make the greatest acquisition announcement of all times. Stay tune

Keytruda is finished!!! Anktiva and BioShield are the future! ImmunityBio IBRX is the company to own! Sell PFE MRNA and MRK. Bioshield clears the Covid virus from our bodies and can reverse long covid which is real! Is it the virus, the jab, or the combination?

https://immunitybio.com/